Simulators that regenerate oscillometric waveforms promise an alternative to clinical trials for validating noninvasive blood pressure devices.
No takes yet. Share an insight, caveat, or question.
May support simulator use to reduce clinical trial burden for BP device validation; leaves open regulatory equivalence and broader adoption.
Amoore et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: